Evidence map›Paper›PMID 41995858›Full record

ArticleActa neuropathologica2026

Neuropathological analysis of an ALS patient carrying a SOD1 missense variant and a C9orf72 repeat expansion.

Tomoko Miki, Sibylle De Bertier, Maria-Del-Mar Amador, Mélusine Nicolas, Claire Guissart, Marion Deret, Elisa Teyssou, François Muratet, Delphine Bohl, Christian S Lobsiger and 5 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tomoko MikiSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Sibylle De BertierSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Maria-Del-Mar AmadorSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Mélusine NicolasSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Claire GuissartLaboratoire de Biochimie et Biologie Moléculaire, CHU Nîmes, Univ Montpellier, Nîmes, France.
Marion DeretSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Elisa TeyssouSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
François MuratetSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Delphine BohlSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Christian S LobsigerSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Séverine BoilléeSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Florence EsselinExplorations Neurologiques et Centre SLA, Univ Montpellier, CHU Gui de Chauliac, INM, INSERM, Montpellier, France.
François SalachasSorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Stéphanie Millecamps *Sorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France.
Danielle Seilhean *Sorbonne Université, Institut du Cerveau-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris (APHP), Hôpital de la Pitié-Salpêtrière, Paris Brain Institute, Paris, France. danielle.seilhean@aphp.fr.

Funding

the Association Française contre les Myopathies (AFM) #19466the Fondation Recherche Médicale (FRM) EQU202103012581
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

C9orf72Dipeptide repeat proteinsDouble variantsPost-mortem tissueSOD1TDP-43

Identifiers

PMID41995858
PMCPMC13090237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.